Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
David Cunningham(Royal Marsden NHS Foundation Trust), A. Norman(Royal Marsden NHS Foundation Trust), Gary Middleton(University Hospitals Birmingham NHS Foundation Trust), Timothy Iveson(University Hospital Southampton NHS Foundation Trust), J. Oates(National Health Service), Sheela Rao(Royal Marsden NHS Foundation Trust), Francis Daniel(Plymouth Hospital), Fareeda Y. Coxon(Newcastle upon Tyne Hospitals NHS Foundation Trust), M. Nicolson, Naureen Starling(Royal Marsden NHS Foundation Trust)
Cited by 2,312
Related Papers
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
|JAMA|2010|1.4k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
|New England Journal of Medicine|2018|1.1k
Oesophageal cancer
|Nature Reviews Disease Primers|2017|1.1k